Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine.

Drugs 97

Drugs Drug Development Pharmaceuticals Production 97

Drug Target Review

DECEMBER 9, 2024

Baker’s model could revolutionise drug development, synthetic biology, and nanotechnology, opening possibilities for new medical treatments, vaccines, nanomaterials, and sensors. Presumably, some of these compositions include proteins synthesised using Bakers AI model.

Engineering 105

Engineering International Drug Development Science 105

Drug Target Review

JANUARY 8, 2024

We are at the forefront of drug development in an area of research called cellular rejuvenation, which is an approach that has the potential to address many diseases of ageing by restoring aged and injured cells to a more youthful and resilient state.

Science 145

Science Disease FDA Approval Clinical Trials 145

Science Daily: Pharmacology News

JUNE 18, 2024

Tests, in mice, of a drug developed by the researchers showed that regulatory T cells can be attracted to specific body parts, boosted in number, and activated to suppress immune response and rebuild tissue.

Treatment 336

Treatment Immune Response Disease Clinical Trials 336

DrugBank

OCTOBER 17, 2024

Data science has emerged as an innovative tool in the biopharmaceutical industry, leveraging the power of machine learning and artificial intelligence to drive innovation and efficiency across the entire drug development lifecycle. These complex molecules require precise engineering to ensure optimal efficacy and safety.

Drug Development 70

Drug Development Metabolic Stability Clinical Trials Drugs 70

BioPharma Drive: Drug Pricing

OCTOBER 25, 2023

“They have the money” and they’re using it to influence drug development, according to the director of the IQVIA Institute for Human Data Science.

Drug Development 156

Drug Development Science Drugs 156

PPD

JANUARY 15, 2025

As a result, drug developers make better decisions more quickly (removing 50% of study timeline whitespace) to bring new therapies to market faster. Accelerate customer speed to market With a modern and integrated user experience, AI solutions put the right data and insights into the right hands in real time.

Clinical Trials 95

Clinical Trials Trials Clinical Research Drug Development 95

Drug Target Review

MARCH 24, 2025

Sujeegar Jeevanandam, an expert with 13 years of experience in life sciences R&D, offers valuable insights into the current state and future trajectory of artificial intelligence in drug discovery. This breakthrough could fundamentally change how drugs are developed and tested.

Clinical Trials 59

Clinical Trials Animal Testing Pharmacokinetics Drugs 59

DrugBank

AUGUST 15, 2024

Drug development is challenging, including not only the complexities of biomolecular drug mechanisms but also the convolutions of regulatory pathways and commercialization strategies. Improved Return on Investment (ROI) Industry-academic partnerships can enhance the financial return on drug development investments.

Drug Development 80

Drug Development Clinical Trials Drugs Therapies 80

Conversations in Drug Development Trends

AUGUST 10, 2023

With so many exciting developments in the last few years, it’s critical for the psychedelic community to come together to reflect on our progress, share the latest discoveries, and discuss the future of psychedelic research. The post 3 Key Takeaways from Psychedelic Science 2023 appeared first on Worldwide Clinical Trials.

Science 98

Science Clinical Trials Trials Clinical Research 98

Drug Target Review

JULY 18, 2023

Artificial Intelligence (AI) is poised to transform the field of target discovery in drug development, offering immense potential to enhance efficacy, personalised medicine, and accelerate the development of innovative compounds. Cavlan explains that “they are brilliant at developing and bringing new drugs to market.”

Drug Development 98

Drug Development Drugs Clinical Development Pharmaceutical Companies 98

FDA Law Blog: Biosimilars

JUNE 27, 2023

James was only one of five life sciences attorneys selected and the only food and drug lawyer to make the list. Amongst his accomplishments, Law360 considered the role James has played in leveraging little-used pathways to FDA approval for often first-ever drugs to treat rare diseases (e.g., Valentine , as a 2023 Rising Star.

Science 81

Science FDA Approval FDA Drug Development 81

LifeSciVC

JANUARY 3, 2024

This is an exciting development both for HotSpot and for the field – not only has the CBM complex been successfully targeted in vitro and in vivo for the first time, but we believe we now have a roadmap for drugging other signaling assemblies relevant to disease.

Drug Development 96

Drug Development Drugs Small Molecule Disease 96

Fierce BioTech

JANUARY 27, 2025

Transforming life sciences with AI, powered by Salesforce Life Sciences Cloud | Drug development and commercialization leads to tremendous advances in medicine and improvements to everyday life, but it often comes at a cost.

Science 52

Science Drug Development Drugs 52

Drug Target Review

AUGUST 7, 2024

The pharmaceutical industry is undergoing a major shift towards the development of breakthrough medicines and advanced therapies. This continued innovation highlights the complexity of the drug development process, particularly as the field is highly regulated by health authorities around the world.

Drug Development 59

Drug Development Clinical Pharmacology Clinical Trials Drugs 59

Fierce BioTech

APRIL 4, 2024

Discover how leading organizations leverage AI to revolutionize operations and expedite drug development, ensuring faster access to life-saving treatments. Gain insights into successful case studies and strategies for leveraging AI in life science innovation. Click here to login. Listing Image Appian-LogoListing-9142023.png

Science 52

Science Compliance Drug Development Treatment 52

Alta Sciences

JANUARY 31, 2025

Getting to the Heart of Science With Mlanie Constant blussier Fri, 01/31/2025 - 16:53 HTML The Stories That Inspire Meet Mlanie Constant, Manager of Microsoft Solutions. Her story is one of perseverance and is a reminder to us all of the important role of drug development.

Science 52

Science Drug Development Drugs 52

Drug Target Review

JANUARY 14, 2025

For more insights, refer to Part 1 of this series, where we explore foundational concepts for early drug discovery workflows. About the authors Dr Raminderpal Singh Dr Raminderpal Singh is a recognised visionary in the implementation of AI across technology and science-focused industries.

Drugs 69

Drugs Protein Expression Science Research 69

Science Daily: Pharmacology News

NOVEMBER 28, 2023

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists -- so far.

Disease 206

Disease Drug Development Therapies Drugs 206

Drug Target Review

DECEMBER 6, 2024

About the authors Dr Raminderpal Singh Dr Raminderpal Singh is a recognised visionary in the implementation of AI across technology and science-focused industries. This iterative nature of scientific investigation often leads to new discoveries as researchers refine their understanding of the data.

RNA 52

RNA Drugs Research Science 52

LifeSciVC

FEBRUARY 27, 2024

By Ivana Magovčević-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC Patients and their care partners are at the center of our work in the life sciences industry – but at what point during the drug development process should companies start to engage these key stakeholders?

Drug Development 64

Drug Development Disease Drugs Treatment 64

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment FDA Approval Drugs 52

Drug Target Review

AUGUST 9, 2024

The science behind drug formulation The formulation of a drug is both an art and a science, requiring a deep understanding of the drug’s chemical and physical properties. 1 Challenges in drug formulation Developing a successful drug formulation is fraught with challenges.

Science 59

Science Drugs Compliance Drug Development 59

SCIENMAG: Medicine & Health

JUNE 14, 2023

Although effective drugs and therapies have been developed for most breast cancer subtypes, triple negative breast cancer lacks the key receptors that these drugs interact with – in other words, it’s negative for the three receptors for which […]

Drug Development 87

Drug Development Drugs Therapies Science 87

Perficient: Drug Development

MARCH 17, 2025

Perficients Clinical Trial Data Collaboration Solution , d eveloped in partnership with a top-five life sciences leader , is a great example of how we bring fresh ideas and game-changing transformative business outcomes for our client.

Clinical Trials 52

Clinical Trials Engineering Trials Science 52

H1 Blog

OCTOBER 30, 2023

The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. Here are 4 predictions for how life sciences companies might be using AI by then. Drug Repurposing AI can analyze existing drugs and their effects to find new therapeutic applications.

Science 59

Science Clinical Trials Trials Engineering 59

thought leadership

JULY 16, 2024

The key to successful drug development in the US is directional and focused navigation of FDA’s Investigational New Drug (IND) process. The data provided in the CMC sections within Module 3 of an IND application provide FDA with information on the drug’s:

Drug Development 53

Drug Development FDA Drugs Science 53

Drug Target Review

OCTOBER 14, 2024

Wilkie’s background as a biochemist and his time at Merck, a leading pharmaceutical company, shaped his early understanding of drug development and business strategy. As someone who describes himself as an “enthusiastic sceptic,” Wilkie is cautious but hopeful about the potential of AI in drug development. “I

Science 52

Science Pharmaceutical Companies Drug Development Pharmaceuticals 52

thought leadership

FEBRUARY 10, 2025

You have a lead candidate formulation for your new drug. We all know the science behind getting to this stage of having multiple candidates or a single lead candidate drug is a daunting task. But dont kid yourself the science is just the beginning. You might be thinking to yourself, okay, now what?

Drug Development 52

Drug Development Science Drugs Production 52

Drug Target Review

MARCH 4, 2025

Phenomix Sciences , led by CEO Mark Bagnall, is using precision medicine to make treatments more targeted and effective. In this interview, Bagnall explains how this approach is improving patient outcomes and driving the development of better obesity drugs. Mark is an entrepreneur and business manager in the healthcare industry.

Therapies 52

Therapies Treatment Clinical Trials Science 52

Perficient: Drug Development

SEPTEMBER 22, 2023

With a highly skilled team of Salesforce consultants and developers with Healthcare and Life Sciences (HLS) experience, Perficient is especially interested in this year’s announcements for the vertical. Here are takeaways for Salesforce clients, consultants, and developers working in HLS.

Science 59

Science Clinical Trials Engineering Production 59

Drug Target Review

DECEMBER 16, 2024

Dr Pooja Hingorani, Senior Medical Director of Oncology Early Development at AbbVie , shares her journey in STEM, from her early days in New Delhi to her impactful career in oncology research and drug development. I opted for medicine due to my love for biological sciences.

Medical Schools 52

Medical Schools Clinical Research Drug Development Trials 52

thought leadership

MARCH 25, 2025

Youre developing an FDA and/or EMA-regulated drug, biologic, or medical device. Throughout the drug development process, your goal is to get to the next regulatory milestone in the most expeditious way possible. Whats the best way to do this? Use your data to tell a compelling story.

Science 52

Science Regulations FDA Drug Development 52

Drug Patent Watch

FEBRUARY 26, 2025

To draft a strong patent application, you need to understand the nuances of biologic drug development, including the production process, stability, and formulation. This requires a deep understanding of the science behind biologics, as well as the regulatory framework governing their development and approval.

Drugs 59

Drugs Government Regulations Compliance 59

Perficient: Drug Development

JUNE 26, 2024

Brand activism is a new buzzword in healthcare and life sciences spaces, and consumers are increasingly expecting their brands of choice to drive social change. So let’s talk about what brand advocacy looks like in healthcare and life sciences and how organizations can begin to build greater advocacy into their plans. The best part?

Science 52

Science Production International Research 52

Drug Target Review

SEPTEMBER 22, 2023

5 Organoids are recognised as New Alternative Methods (NAMs) in drug development. This recognition was codified by the United States Food and Drug Administration (FDA) in 2022 with the signing of the FDA Modernisation Act 2.0 This can aid in the development of safer, more effective therapeutic strategies.

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. Kristina is a pharmacist and holds a PhD in Medical Science from Linköping University.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111